(3S,6S,9R,12S)-6-(4-Aminobutyl)-12-benzyl-3-[(1R)-1-(benzyloxy)ethyl]-9-(1H-indol-3-ylmethyl)-1,4,7,10,13-pentaazacycloicosane-2,5,8,11,14-pentone(CAS: 84211-54-1)

This compound falls under the regulatory guidelines of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), and must comply with the REACH regulations in the European Union. In the USA, it must meet FDA and EPA requirements for chemical substances. Specific handling, storage, and disposal guidelines should be followed to ensure compliance with local and international regulations.

Synthesis alternatives include using isomers or analogs such as (3R,6R,9S,12S)-6-(4-Aminobutyl)-12-benzyl-3-[(1S)-1-(benzyloxy)ethyl]-9-(1H-indol-3-ylmethyl)-1,4,7,10,13-pentaazacycloicosane-2,5,8,11,14-pentone, or substituting the aminobutyl group with other amino-containing groups. These alternatives can offer similar functionalities while potentially simplifying the synthesis process.

The market for this compound is primarily driven by its use in research and development for pharmaceuticals and biotech applications. Recent trends indicate growing interest in its potential as an intermediate in drug synthesis and as a candidate for medicinal chemistry studies. Research is focused on its pharmacological properties and its application in targeted therapies.

Waste containing this compound should be collected in appropriate containers and stored in a secure location. Proper incineration or professional waste disposal services should be utilized. Ensure that all handling follows environmental protection guidelines to prevent contamination and ensure safe disposal. Consult local regulations for specific disposal requirements.